Cytotoxic effects of p-cresol in renal epithelial tubular cells

Blood Purification

Volumn 36, Issue 3-4, 2014, Pages 219-225

  Brocca, Alessandra ^a,b   Virzì, Grazia Maria ^a   De Cal, Massimo ^a   Cantaluppi, Vincenzo ^c   Ronco, Claudio ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Department of Information Engineering University of Padua ^*  (Italy)

Author keywords

Chronic kidney disease; Cytotoxicity; p Cresol; Renal tubular cells; Uremia; Uremic toxins

Indexed keywords

CASPASE 3; LIPOCORTIN 5; PARA CRESOL;

APOPTOSIS; ARTICLE; CELL DEATH; CELL VIABILITY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CYTOFLUOROMETRY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KIDNEY TUBULE CELL; MORTALITY; NECROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; DNA FRAGMENTATION; ENZYME ACTIVITY; FLOW CYTOMETER; IN VITRO STUDY; NEPHROTOXICITY; QUANTITATIVE ANALYSIS;

APOPTOSIS; CELL LINE; CELLS, CULTURED; CRESOLS; DNA FRAGMENTATION; EPITHELIAL CELLS; HUMANS; KIDNEY TUBULES; TOXINS, BIOLOGICAL;

EID: 84897559318     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000356370     Document Type: Article

References (37)

1. Vanholder R, De Smet R: Pathophysiologic effects of uremic retention solutes. J Am Soc Nephrol 1999; 10: 1815-1823.
2. Neirynck N, Vanholder R, Schepers E, Eloot S, Pletinck A, Glorieux G: An update on uremic toxins. Int Urol Nephrol 2013; 45: 139-150.
3. Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W: Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934-1943.
4. Vanholder R, Baurmeister U, Brunet P, Cohen G, Glorieux G, Jankowski J: A bench to bedside view of uremic toxins. J Am Soc Nephrol 2008; 19: 863-870.
5. Descamps-Latscha B: The immune system in end-stage renal disease. Curr Opin Nephrol Hypertens 1993; 2: 883-891.
6. Vanholder R, De Smet R, Lesaffer G: p-cresol: a toxin revealing many neglected but relevant aspects of uraemic toxicity. Nephrol Dial Transplant 1999; 14: 2813-2815.
7. Brega A, Prandini P, Amaglio C, Pafumi E: Determination of phenol, m-, o-and p-cresol, p-aminophenol and p-nitrophenol in urine by high-performance liquid chromatography. J Chromatogr 1990; 535: 311-316.
8. Niwa T: Phenol and p-cresol accumulated in uremic serum measured by HPLC with fluorescence detection. Clin Chem 1993; 39: 108-111.
9. Niwa T, Maeda K, Ohki T, Saito A, Kobayashi K: A gas chromatographic-mass spectrometric analysis for phenols in uremic serum. Clin Chim Acta 1981; 110: 51-57.
10. Hida M, Aiba Y, Sawamura S, Suzuki N, Satoh T, Koga Y: Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron 1996; 74: 349-355.
11. Ogata N, Matsushima N, Shibata T: Pharmacokinetics of wood creosote: glucuronic acid and sulfate conjugation of phenolic compounds. Pharmacology 1995; 51: 195-204.
12. Geypens B, Claus D, Evenepoel P, Hiele M, Maes B, Peeters M, Rutgeerts P, Ghoos Y: Influence of dietary protein supplements on the formation of bacterial metabolites in the colon. Gut 1997; 41: 70-76.
13. Vanholder R, Smet RD, Glorieux G, Dhondt A: Survival of hemodialysis patients and uremic toxin removal. Artif Organs 2003; 27: 218-223.
14. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y: Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms. Kidney Int 2003; 64: 2238-2243.
15. Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y: Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 2006; 69: 1081-1087.
16. Meijers BK, Bammens B, De Moor B, Verbeke K, Vanrenterghem Y, Evenepoel P: Free pcresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 2008; 73: 1174-1180.
17. Nowak I, Shaw LM: Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics. Clin Chem 1995; 41: 1011-1017.
18. De Smet R, Glorieux G, Hsu C, Vanholder R: p-cresol and uric acid: two old uremic toxins revisited. Kidney Int Suppl 1997; 62:S8-S11.
19. Wratten ML, Tetta C, De Smet R, Neri R, Sereni L, Camussi G, Vanholder R: Uremic ultrafiltrate inhibits platelet-activating factor synthesis. Blood Purif 1999; 17: 134-141.
20. Zhu JZ, Zhang J, Yang K, Du R, Jing YJ, Lu L, Zhang RY: p-Cresol, but not p-cresylsulphate, disrupts endothelial progenitor cell function in vitro. Nephrol Dial Transplant 2012; 27: 4323-4330.
21. Dou L, Cerini C, Brunet P, Guilianelli C, Moal V, Grau G, De Smet R, Vanholder R, Sampol J, Berland Y: p-Cresol, a uremic toxin, decreases endothelial cell response to inflammatory cytokines. Kidney Int 2002; 62: 1999-2009.
22. Ferrante A: Inhibition of human neutrophil locomotion by the polyamine oxidase-polyamine system. Immunology 1985; 54: 785-790.
23. Horl WH: Uremic toxins: new aspects. J Nephrol 2000; 13(suppl 3):S83-S88.
24. Vanholder R, De Smet R, Waterloos MA, Van Landschoot N, Vogeleere P, Hoste E, Ringoir S: Mechanisms of uremic inhibition of phagocyte reactive species production: characterization of the role of p-cresol. Kidney Int 1995; 47: 510-517.
25. Horl WH, Cohen JJ, Harrington JT, Madias NE, Zusman CJ: Atherosclerosis and uremic retention solutes. Kidney Int 2004; 66: 1719-1731.
26. De Smet R, David F, Sandra P, Van Kaer J, Lesaffer G, Dhondt A, Lameire N, Vanholder R: A sensitive HPLC method for the quantification of free and total p-cresol in patients with chronic renal failure. Clin Chim Acta 1998; 278: 1-21.
27. Dou L, Bertrand E, Cerini C, Faure V, Sampol J, Vanholder R, Berland Y, Brunet P: The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 2004; 65: 442-451.
28. Cerini C, Dou L, Anfosso F, Sabatier F, Moal V, Glorieux G, De Smet R, Vanholder R, Dignat-George F, Sampol J, Berland Y, Brunet P: p-cresol, a uremic retention solute, alters the endothelial barrier function in vitro. Thromb Haemost 2004; 92: 140-150.
29. Cohen G, Glorieux G, Thornalley P, Schepers E, Meert N, Jankowski J, Jankowski V, Argiles A, Anderstam B, Brunet P, Cerini C, Dou L, Deppisch R, Marescau B, Massy Z, Perna A, Raupachova J, Rodriguez M, Stegmayr B, Vanholder R, Horl WH: Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro-towards a standardized approach for research on uraemia. Nephrol Dial Transplant 2007; 22: 3381-3390.
30. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F: Features of apoptotic cells measured by flow cytometry. Cytometry 1992; 13: 795-808.
31. De Smet R, Van Kaer J, Van Vlem B, De Cubber A, Brunet P, Lameire N, Vanholder R: Toxicity of free p-cresol: a prospective and cross-sectional analysis. Clin Chem 2003; 49: 470-478.
32. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC: Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998; 396: 580-584.
33. Cendoroglo M, Jaber BL, Balakrishnan VS, Perianayagam M, King AJ, Pereira BJ: Neutrophil apoptosis and dysfunction in uremia. J Am Soc Nephrol 1999; 10: 93-100.
34. Fink SL, Cookson BT: Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun 2005; 73: 1907-1916.
35. de Carvalho JT Jr, Dalboni MA, Watanabe R, Peres AT, Goes MA, Manfredi SR, Canziani ME, Cendoroglo GS, Guimaraes-Souza N, Batista MC, Cendoroglo M: Effects of spermidine and p-cresol on polymorphonuclear cell apoptosis and function. Artif Organs 2011; 35:E27-E32.
36. Sardenberg C, Suassuna P, Andreoli MC, Watanabe R, Dalboni MA, Manfredi SR, dos Santos OP, Kallas EG, Draibe SA, Cendoroglo M: Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function. Nephrol Dial Transplant 2006; 21: 160-165.
37. Lin CJ, Wu CJ, Pan CF, Chen YC, Sun FJ, Chen HH: Serum protein-bound uraemic toxins and clinical outcomes in haemodialysis patients. Nephrol Dial Transplant 2010; 25: 3693-3700.